EP3574309A4 - Immunodosage à base de particules magnétiques et ses procédés d'utilisation - Google Patents

Immunodosage à base de particules magnétiques et ses procédés d'utilisation Download PDF

Info

Publication number
EP3574309A4
EP3574309A4 EP18744906.1A EP18744906A EP3574309A4 EP 3574309 A4 EP3574309 A4 EP 3574309A4 EP 18744906 A EP18744906 A EP 18744906A EP 3574309 A4 EP3574309 A4 EP 3574309A4
Authority
EP
European Patent Office
Prior art keywords
immunt
test
magnetic particle
particle based
magnetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18744906.1A
Other languages
German (de)
English (en)
Other versions
EP3574309A1 (fr
Inventor
Andrew Ward
Arun Richard CHANDRASEKARAN
Daniel Chen
Christopher Blanchard
Padric GARDEN
Bradley DEMARCO
Joshua Forman
Mounir A. KOUSSA
Lisa CALDWELL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vital Biosciences Inc
Original Assignee
Vital Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vital Biosciences Inc filed Critical Vital Biosciences Inc
Publication of EP3574309A1 publication Critical patent/EP3574309A1/fr
Publication of EP3574309A4 publication Critical patent/EP3574309A4/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
EP18744906.1A 2017-01-26 2018-01-26 Immunodosage à base de particules magnétiques et ses procédés d'utilisation Pending EP3574309A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762450623P 2017-01-26 2017-01-26
US201762544393P 2017-08-11 2017-08-11
PCT/US2018/015440 WO2018140719A1 (fr) 2017-01-26 2018-01-26 Immunodosage à base de particules magnétiques et ses procédés d'utilisation

Publications (2)

Publication Number Publication Date
EP3574309A1 EP3574309A1 (fr) 2019-12-04
EP3574309A4 true EP3574309A4 (fr) 2020-11-11

Family

ID=62978769

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18744906.1A Pending EP3574309A4 (fr) 2017-01-26 2018-01-26 Immunodosage à base de particules magnétiques et ses procédés d'utilisation

Country Status (4)

Country Link
EP (1) EP3574309A4 (fr)
CN (1) CN110462383A (fr)
CA (1) CA3051475A1 (fr)
WO (1) WO2018140719A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112823048A (zh) * 2018-07-27 2021-05-18 维拉维斯公司 消除和富集的方法
KR102138192B1 (ko) * 2018-12-28 2020-07-27 (주)프로테옴텍 다수 개의 검사선을 구비한 임신진단용 면역크로마토그래피 스트립 및 이를 포함하는 임신진단키트
US12007388B2 (en) * 2019-08-22 2024-06-11 The Hong Kong University Of Science And Technology System for single-molecule isolation for cell populations and single cells, and methods and uses thereof
CN110618265B (zh) * 2019-09-12 2023-04-18 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） 一种沙丁胺醇的可视化检测方法
CN111024938B (zh) * 2019-11-27 2023-05-26 武汉市农业科学院 一种病原微生物快速检测方法
GB202006800D0 (en) * 2020-05-07 2020-06-24 Cambridge Entpr Ltd Carrier system and method
WO2022029732A1 (fr) * 2020-08-07 2022-02-10 Vital Biosciences Inc. Modulation cinétique pour la détection d'analyte magnétique
US20240295549A1 (en) * 2020-08-07 2024-09-05 Vital Biosciences Inc. Multiplexed analyte detection
GB202019024D0 (en) * 2020-12-02 2021-01-13 Paraytec Ltd Diagnostic testing
CN112710858A (zh) * 2020-12-15 2021-04-27 深圳天辰医疗科技有限公司 试剂盒及其制备方法和应用
CN112526121B (zh) * 2020-12-18 2022-11-18 深圳普门科技股份有限公司 血清淀粉样蛋白a检测试剂盒及其检测系统
CN112748096B (zh) * 2020-12-29 2022-03-18 山西大学 一种磺胺二甲氧嘧啶的室温磷光检测方法及应用
CN112763484B (zh) * 2021-01-27 2022-05-03 南京医科大学 一种基于比色生物传感器检测谷胱甘肽和/或过氧化氢的方法
CN113373156A (zh) * 2021-06-30 2021-09-10 四川携光生物技术有限公司 自身免疫性脑炎相关的nmdar重组蛋白、其编码序列、制法和应用
CN114152741B (zh) * 2021-11-18 2022-08-19 上海北昂医药科技股份有限公司 一种提高有效微珠比例的dELISA样品及其制备与检测方法
CN113960313B (zh) * 2021-12-22 2022-04-12 上海思路迪医学检验所有限公司 一种外泌体alk融合蛋白磁免疫化学发光检测试剂盒
CN114739986B (zh) * 2022-04-22 2025-03-21 东南大学 TiO2纳米花负载CdTe量子点的电化学发光免疫传感器及其制备方法和应用
CN114706023A (zh) * 2022-06-06 2022-07-05 中国科学技术大学 生物分子相互作用的磁学检测方法
WO2024102748A1 (fr) * 2022-11-07 2024-05-16 Kephera Diagnostics, Llc Méthodes, instruments de diagnostic et kits de détection de maladies
CN115815588B (zh) * 2022-11-30 2024-06-28 山东省淡水渔业研究院（山东省淡水渔业监测中心） 基于纳米钯/多层空心球状Pd/CuO@NiO检测水产品中孔雀石绿的方法
WO2024175169A1 (fr) * 2023-02-20 2024-08-29 STILLER, Olaf Procédé permettant de détecter directement la présence d'une substance de test
CN116392591B (zh) * 2023-04-06 2025-08-08 暨南大学 基于硒化钼的磁性纳米捕捉系统制备方法和应用
CN118441163B (zh) * 2024-04-16 2025-12-19 江西理工大学 一种从废旧钕铁硼磁体中回收镓的方法
CN119375196A (zh) * 2024-10-29 2025-01-28 福建省妇幼保健院 一种基于核壳结构上转换纳米粒子检测microRNA的方法
CN120009554A (zh) * 2025-04-21 2025-05-16 天津市肿瘤医院（天津医科大学肿瘤医院） 一种用于ProGRP检测的免疫平台及制备方法和应用
CN121276065B (zh) * 2025-12-02 2026-03-31 湖北大学 一种基于尿液合成dna检测aki的生物传感器及应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065209A1 (en) * 2009-08-31 2011-03-17 Mbio Diagnostics, Inc. Integrated Sample Preparation and Analyte Detection
WO2013189502A1 (fr) * 2012-06-22 2013-12-27 Scandinavian Micro Biodevices Aps Procédé et système permettant la détermination quantitative ou qualitative d'un composé cible
US20140170767A1 (en) * 2012-11-30 2014-06-19 Korea Institute Of Science And Technology Method for diagnosing biomarkers and biomarker diagnosis kit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024941A1 (fr) * 1998-10-27 2000-05-04 Clinical Micro Sensors, Inc. Detection d'analytes cibles au moyen de particules et d'electrodes
US6607922B2 (en) * 2000-03-17 2003-08-19 Quantum Design, Inc. Immunochromatographic assay method and apparatus
CN100420947C (zh) * 2005-05-30 2008-09-24 孙东旭 用单一捕获剂定量检测特异性分析物的方法及其试剂盒
US10488408B2 (en) * 2006-05-09 2019-11-26 Koninklijke Philips N.V. Detection of target molecules in a sample by using a magnetic field
US8873038B2 (en) * 2010-10-27 2014-10-28 The Board Of Trustees Of The University Of Illinois Tailored raman spectrocopic probes for ultrasensitive and highly multiplexed assays
EP2629095A1 (fr) * 2012-02-17 2013-08-21 Biosure R & T Cell Co. Détection de cibles de protéine mycobactérienne incluant des points Quantum et séparation immunomagnétique
US9599610B2 (en) * 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9891227B2 (en) * 2014-05-02 2018-02-13 Academia Sinica Ultrasensitive detection of a biological target by aptamer-conjugated gold nanoparticles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065209A1 (en) * 2009-08-31 2011-03-17 Mbio Diagnostics, Inc. Integrated Sample Preparation and Analyte Detection
WO2013189502A1 (fr) * 2012-06-22 2013-12-27 Scandinavian Micro Biodevices Aps Procédé et système permettant la détermination quantitative ou qualitative d'un composé cible
US20140170767A1 (en) * 2012-11-30 2014-06-19 Korea Institute Of Science And Technology Method for diagnosing biomarkers and biomarker diagnosis kit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018140719A1 *

Also Published As

Publication number Publication date
EP3574309A1 (fr) 2019-12-04
CN110462383A (zh) 2019-11-15
CA3051475A1 (fr) 2018-08-02
WO2018140719A1 (fr) 2018-08-02

Similar Documents

Publication Publication Date Title
EP3574309A4 (fr) Immunodosage à base de particules magnétiques et ses procédés d'utilisation
EP3701245A4 (fr) Système et procédé de mesure de particules
EP4008728C0 (fr) Molécules de liaison à cd70 et leurs procédés d'utilisation
EP3526256C0 (fr) Anticorps anti-lag-3 et leurs procédés d'utilisation
EP3568467A4 (fr) Lymphocytes t modifiés et leurs procédés d'utilisation
EP4088708C0 (fr) Système et procédé d'évaluation de l'ajustement d'un exosquelette
EP3496859C0 (fr) Sonde de collecte et son procédé d'utilisation
EP3618896A4 (fr) Appareil d'injection et procédé d'utilisation
EP3554630A4 (fr) Dispositif de défibrillateur externe automatique et procédés d'utilisation
EP3641868A4 (fr) Gaine extensible et méthodes d'utilisation de celle-ci
EP3310378C0 (fr) Anticorps anti-c1 et leurs procédés d'utilisation
EP3548136A4 (fr) Dispositif de neuromodulation et son procédé d'utilisation
EP3704254A4 (fr) Compositions de cas12c et procédés d'utilisation
EP3464360C0 (fr) Anticorps anti-tim-3 et leurs méthodes d'utilisation
EP3574382A4 (fr) Véhicule guidé automatisé et procédé d'utilisation
EP3515478A4 (fr) Anticorps pour siglec-15 et leurs méthodes d'utilisation
EP3596960A4 (fr) Système de positionnement précis et procédé d'utilisation associé
EP3478723A4 (fr) Anticorps spécifiques de pd-l1 et procédés pour les utiliser
EP3490990C0 (fr) Modulateurs nmda a base de spirolactams et leur methode d'utilisation
EP3635748C0 (fr) Système de confinement de plasma et procédés d'utilisation
EP3490974C0 (fr) Modulateurs nmda a base de spirolactams et leur methode d'utilisation
EP3562931A4 (fr) Dispositifs de détection microbienne et leurs procédés d'utilisation
EP3922649C0 (fr) Anticorps anti-htra1 et leurs procédés d'utilisation
EP3635106A4 (fr) Populations de cellules transdifférenciées et leurs procédés d'utilisation
EP3490993C0 (fr) Modulateurs nmda a base de spirolactams et leur methode d'utilisation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190730

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: G01N0021760000

Ipc: G01N0033553000

A4 Supplementary search report drawn up and despatched

Effective date: 20201012

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/553 20060101AFI20201006BHEP

Ipc: G01N 33/543 20060101ALI20201006BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230515

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230714